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ABSTRACT 
Background 
Inhaled corticosteroids forms the cornerstone of asthma therapy. With 
increasing incidence of childhood asthma, safety profile of ICS in children remains a 
subject of concern for pediatricians. This study aims to assess the alterations in 
glycaemic and lipid profile parameters in asthmatic children on inhaled Budesonide 
compared to children on as and when needed salbutamol alone. 
Methods 
This case control study was conducted between December 2016 and September 
2017 in the Pediatric OPD and asthma clinic of Institute of social pediatrics, Stanley 
medical college. 
79 asthmatic children (case group) on inhaled Budesonide for a minimum of 6 
months in addition to as and when needed salbutamol and 40 asthmatic children on 
inhaled salbutamol as and when needed alone (control group) were included in the 
study.4ml of blood in fasting state was drawn from both the groups for FBS, HbA1C, 
and fasting lipid profile. Alterations in glycaemic and lipid profile were analyzed in 
both the groups. The alterations were also analyzed among the cases with respect to 
dosage of inhaled Budesonide, duration of Budesonide use and symptom control of 
asthma. 
Results 
None of the children had glycaemic and lipid parameters in 
diabetic/dyslipidemia range. However the risk of having a borderline high LDL-C was 
6 times higher (OR6.410 CI 0.239-171.727) and the risk of having borderline low 
HDL-C was 3 times higher (OR 3.635 CI 0.951-13.891) among asthmatic children in 
the Budesonide group as compared to the salbutamol group. 
Among asthmatic children on inhaled Budesonide lower values of HDL-C was 
observed in children with uncontrolled asthma as compared to partly and well 
controlled asthma (p=0.002) and also with children on higher doses of Budesonide as 
compared to medium and low dosages of Budesonide. (p=0.0005). 
Conclusion 
Pediatricians must carefully monitor metabolic parameters especially HDL-C, 
LDL-C and serum triglyceride levels in asthmatic children on inhaled 
Budesonide,especially in children on high dosages and those with uncontrolled 
asthma. 
Further trials with other ICS,larger sample size, longer duration of use of ICS is 
required to assess the alterations in metabolic parameters and planning follow up of 
children when started on ICS. 
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